October 21, 2019
The full Third Circuit on Monday declined to reconsider a panel's September ruling sending antitrust claims from Rochester Drug Cooperative Inc. over allegedly inflated prices it paid for the Johnson & Johnson immunosuppressant Remicade to arbitration, denying RDC's petition for a rehearing en banc filed earlier this month.
September 13, 2019
The Third Circuit ruled on Friday that antitrust claims from Rochester Drug Cooperative Inc. over allegedly inflated prices it paid for the Johnson & Johnson immunosuppressant Remicade fell within the scope of an arbitration clause in a distribution agreement between the two companies.
July 09, 2019
A Third Circuit panel pressed an attorney for Rochester Drug Cooperative Inc. during a hearing Tuesday over whether antitrust claims involving allegedly inflated prices it paid for the Johnson & Johnson immunosuppressant Remicade fall under an arbitration clause in a distribution agreement between the two companies.